Latest News & Features
Big Pharma
GSK has revealed that it will buy Novartis out of their joint consumer healthcare business. 27 March 2018
Americas
A US judge handed a win to Shire late last week, finding that a generic version of its attention deficit hyperactivity disorder drug Adderall XR would infringe Shire’s patents. 27 March 2018
Genetics
There is a complex relationship between the advancing global bioeconomy and the regulatory frameworks covering access to genetic resources, says Diana Jungmann of Di Blasi Parente & Associados. 26 March 2018
Europe
The English High Court has rejected molecular diagnostics company Premaitha Health’s attempt to stop a patent infringement claim. 26 March 2018
Americas
UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents. 26 March 2018
Americas
Novartis and Harvard University have teamed up to develop Harvard’s proprietary biomaterial systems to deliver cancer immunotherapies. 23 March 2018
Americas
Novartis has accused competitor Regeneron of patent infringement through the latter’s sale of Eylea and Zaltrap. 22 March 2018
Europe
Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure. 22 March 2018
Big Pharma
The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions. 22 March 2018
Americas
Johnson & Johnson has revealed plans to sell LifeScan, its blood glucose monitoring unit, for $2.1 billion. 21 March 2018